Expert Review of Neurotherapeutics, Volume 17, Issue 1 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Neurotherapeutics, Volume 17, Issue 1 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Foreword

Introduction
Research update on Alzheimer’s disease and introduction to the Expert Review of Neurotherapeutics special issue
Serge Gauthier
Pages: 1-2
Published online: 09 Dec 2016
CitationforResearch update on Alzheimer’s disease and introduction to the Expert Review of Neurotherapeutics special issue | Full Text | References | PDF (232 KB)
  • 1028 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Plasma amyloid beta peptides: an Alzheimer’s conundrum or a more accessible Alzheimer’s biomarker?
Anne Poljak & Perminder Singh Sachdev
Pages: 3-5
Published online: 31 Jul 2016
First Page PreviewforPlasma amyloid beta peptides: an Alzheimer’s conundrum or a more accessible Alzheimer’s biomarker? | Full Text | References | PDF (300.9 KB)
  • 1667 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Analysis of recent failures of disease modifying therapies in Alzheimer’s disease suggesting a new methodology for future studies
Hamid Reza Amanatkar, Bill Papagiannopoulos & George Thomas Grossberg
Pages: 7-16
Published online: 09 Jun 2016
AbstractforAnalysis of recent failures of disease modifying therapies in Alzheimer’s disease suggesting a new methodology for future studies | Full Text | References | PDF (750.7 KB)
  • 706 Views
  • 37 CrossRef citations
  • 0Altmetric
Review
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
William James Deardorff & George T Grossberg
Pages: 17-32
Published online: 24 Jun 2016
AbstractforTargeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics | Full Text | References | PDF (1.2 MB) | Supplemental
  • 986 Views
  • 48 CrossRef citations
  • 0Altmetric
Review
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
Antonella Tramutola, Chiara Lanzillotta & Fabio Di Domenico
Pages: 33-45
Published online: 14 Oct 2016
AbstractforTargeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies | Full Text | References | PDF (1.3 MB)
  • 674 Views
  • 46 CrossRef citations
  • 0Altmetric
Review
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
Simone Lista & Harald Hampel
Pages: 47-57
Published online: 01 Jul 2016
AbstractforSynaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease | Full Text | References | PDF (824.7 KB)
  • 959 Views
  • 58 CrossRef citations
  • 0Altmetric
Review
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology
Antonella Tramutola, Andrea Arena, Chiara Cini, D. Allan Butterfield & Eugenio Barone
Pages: 59-75
Published online: 20 Oct 2016
AbstractforModulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology | Full Text | References | PDF (1.3 MB)
  • 940 Views
  • 26 CrossRef citations
  • 0Altmetric
Review
Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
Susana Cardoso, Raquel M. Seiça & Paula I. Moreira
Pages: 77-91
Published online: 08 Jul 2016
AbstractforMitochondria as a target for neuroprotection: implications for Alzheimer´s disease | Full Text | References | PDF (1.2 MB)
  • 720 Views
  • 22 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
P. Moondra et al.
Review Article | Published online: 9 Jul 2024
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease
James E. Eaton et al.
Editorial | Published online: 9 Jul 2024
Free Access
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias
Marie Beaudin et al.
Review Article | Published online: 9 Jul 2024
Risk of suicide and suicide-related events in subjects treated with antiseizure medications
Boulenouar Mesraoua et al.
Review Article | Published online: 8 Jul 2024
View all latest articles